Literature DB >> 8665992

Polymorphic inhibition of human angiotensin I-converting enzyme by enalaprilat.

E J Lee1.   

Abstract

Many individuals possess an allele of the angiotensin I-converting enzyme (ACE) gene, which contains an extra 287-kb fragment in intron 16 (Rigat et al. 1992). Although the functionality of this fragment is at present unclear, the absence (deletion, D) or presence (insertion, I) of this fragment appears to be related to both the amount and activity of circulating ACE. This paper reports the possible polymorphic response of ACE to the ACE inhibitor enalaprilat in 54 normal Chinese subjects that is independent of the I/D polymorphism. The kinetics of ACE inhibition with enalaprilat was studied in serum from 54 normal Chinese subjects. Enalaprilat appKi ranged between 0.46 and 2.16 nM. An antimode was observed at 1.4 nM. Four subjects could be characterized as being poor responders to enalaprilat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8665992     DOI: 10.1007/bf00192376

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  The angiotensin 1-converting enzyme genetic polymorphism is associated with altered substrate affinity.

Authors:  E J Lee
Journal:  Pharmacogenetics       Date:  1994-04

Review 2.  Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.

Authors:  H R Kaplan; D G Taylor; S C Olson; L K Andrews
Journal:  Angiology       Date:  1989-04       Impact factor: 3.619

3.  Population genetics of the angiotensin-converting enzyme in Chinese.

Authors:  E J Lee
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

4.  Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-I genes with essential hypertension.

Authors:  B J Morris; R Y Zee; L H Ying; L R Griffiths
Journal:  Clin Sci (Lond)       Date:  1993-08       Impact factor: 6.124

Review 5.  Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions.

Authors:  E W Petrillo; M A Ondetti
Journal:  Med Res Rev       Date:  1982 Jan-Mar       Impact factor: 12.944

6.  Inhibition of angiotensin converting enzyme: mechanism and substrate dependence.

Authors:  R Shapiro; J F Riordan
Journal:  Biochemistry       Date:  1984-10-23       Impact factor: 3.162

7.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

8.  The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

Authors:  L Wei; F Alhenc-Gelas; P Corvol; E Clauser
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

9.  Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension.

Authors:  R Y Zee; Y K Lou; L R Griffiths; B J Morris
Journal:  Biochem Biophys Res Commun       Date:  1992-04-15       Impact factor: 3.575

10.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.